Reig Jofre informs on the new commercial activity in the Philippines
6 September 2017
Reig Jofre continues to progress on its penetration in Asia with the marketing of an injectable antibiotic in the Philippines
- Reig Jofre begins the marketing in the Philippines of Bizafrox (cefuroxime) 750mg, a cephalosporanic injectable indicated in bacterial infections.
- The Asian market is one of the strategic markets for Reig Jofre, which went from 4% to 7% in the company’s sales contribution in2016.
- Reig Jofre is finalizing the registration of new products for this market.